Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis

The 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) model leads to chronic cholestatic liver injury and therefore resembles human diseases such as sclerosing cholangitis and forms of metabolic liver diseases. The role of the interleukin-6/glycoprotein 130 (gp130) system in this context is still unde...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Plum, Werner (VerfasserIn) , Tschaharganeh, Darjus-Felix (VerfasserIn) , Kroy, Daniela C. (VerfasserIn) , Corsten, Eva (VerfasserIn) , Erschfeld, Stephanie (VerfasserIn) , Dierssen, Uta (VerfasserIn) , Wasmuth, Hermann (VerfasserIn) , Trautwein, Christian (VerfasserIn) , Streetz, Konrad L. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 16 December 2010
In: The American journal of pathology
Year: 2010, Jahrgang: 176, Heft: 5, Pages: 2236-2246
ISSN:1525-2191
DOI:10.2353/ajpath.2010.090469
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2353/ajpath.2010.090469
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S000294401060020X
Volltext
Verfasserangaben:Werner Plum, Darjus F. Tschaharganeh, Daniela C. Kroy, Eva Corsten, Stephanie Erschfeld, Uta Dierssen, Hermann Wasmuth, Christian Trautwein, and Konrad L. Streetz

MARC

LEADER 00000caa a2200000 c 4500
001 184459811X
003 DE-627
005 20230710140443.0
007 cr uuu---uuuuu
008 230504s2010 xx |||||o 00| ||eng c
024 7 |a 10.2353/ajpath.2010.090469  |2 doi 
035 |a (DE-627)184459811X 
035 |a (DE-599)KXP184459811X 
035 |a (OCoLC)1389805945 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Plum, Werner  |e VerfasserIn  |0 (DE-588)143201441  |0 (DE-627)643889450  |0 (DE-576)335606865  |4 aut 
245 1 0 |a Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis  |c Werner Plum, Darjus F. Tschaharganeh, Daniela C. Kroy, Eva Corsten, Stephanie Erschfeld, Uta Dierssen, Hermann Wasmuth, Christian Trautwein, and Konrad L. Streetz 
264 1 |c 16 December 2010 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.05.2023 
520 |a The 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) model leads to chronic cholestatic liver injury and therefore resembles human diseases such as sclerosing cholangitis and forms of metabolic liver diseases. The role of the interleukin-6/glycoprotein 130 (gp130) system in this context is still undefined. Therefore, conditional gp130 knockout and knockin mice were used to achieve hepatocyte-specific deletions of gp130 (gp130Δhepa), gp130-dependent ras (gp130ΔhepaRas), and signal transducer and activator of transcription (STAT) (gp130ΔhepaSTAT) activation. These mice were treated with a DDC-containing diet and analyzed over time. Mice deficient in hepatic gp130 and STAT signaling showed increased and earlier mortality than wild-type and gp130ΔhepaRas animals. Over time, significantly more apoptosis and cholestasis became evident in gp130Δhepa and gp130ΔhepaSTAT mice. These mice also displayed increased tumor necrosis factor-α expression, a diminished acute-phase response (lack of STAT3 and serum amyloid A activation), and enhanced immune cell infiltration in the liver. These were associated with stronger periportal oval cell activation. In addition, DDC treatment in gp130Δhepa and gp130ΔhepaSTAT mice resulted in significantly stronger hepatic stellate cell activation. Long-term analysis revealed the development of severe liver fibrosis in gp130Δhepa and gp130ΔhepaSTAT animals, as evidenced by increased collagen accumulation. Here we demonstrate that gp130/STAT signaling in hepatocytes provides protection in a cholestatic hepatitis mouse model. STAT3-dependent signaling pathways in hepatocytes protect from apoptosis and tissue injury, which subsequently reduce oval cell activation and prevent fibrosis progression. 
700 1 |a Tschaharganeh, Darjus-Felix  |e VerfasserIn  |0 (DE-588)141083565  |0 (DE-627)624916979  |0 (DE-576)322090024  |4 aut 
700 1 |a Kroy, Daniela C.  |e VerfasserIn  |4 aut 
700 1 |a Corsten, Eva  |e VerfasserIn  |4 aut 
700 1 |a Erschfeld, Stephanie  |e VerfasserIn  |4 aut 
700 1 |a Dierssen, Uta  |e VerfasserIn  |4 aut 
700 1 |a Wasmuth, Hermann  |e VerfasserIn  |4 aut 
700 1 |a Trautwein, Christian  |e VerfasserIn  |4 aut 
700 1 |a Streetz, Konrad L.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t The American journal of pathology  |d New York [u.a.] : Elsevier, 1925  |g 176(2010), 5 vom: Dez., Seite 2236-2246  |h Online-Ressource  |w (DE-627)271352906  |w (DE-600)1480207-7  |w (DE-576)078591732  |x 1525-2191  |7 nnas  |a Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis 
773 1 8 |g volume:176  |g year:2010  |g number:5  |g month:12  |g pages:2236-2246  |g extent:11  |a Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis 
856 4 0 |u https://doi.org/10.2353/ajpath.2010.090469  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S000294401060020X  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230504 
993 |a Article 
994 |a 2010 
998 |g 141083565  |a Tschaharganeh, Darjus-Felix  |m 141083565:Tschaharganeh, Darjus-Felix  |d 910000  |d 912000  |e 910000PT141083565  |e 912000PT141083565  |k 0/910000/  |k 1/910000/912000/  |p 2 
999 |a KXP-PPN184459811X  |e 4317866080 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis","title":"Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis"}],"person":[{"family":"Plum","given":"Werner","display":"Plum, Werner","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Tschaharganeh","given":"Darjus-Felix","display":"Tschaharganeh, Darjus-Felix","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Kroy","given":"Daniela C.","roleDisplay":"VerfasserIn","display":"Kroy, Daniela C.","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Corsten, Eva","given":"Eva","family":"Corsten"},{"family":"Erschfeld","given":"Stephanie","display":"Erschfeld, Stephanie","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Dierssen, Uta","roleDisplay":"VerfasserIn","given":"Uta","family":"Dierssen"},{"given":"Hermann","family":"Wasmuth","role":"aut","roleDisplay":"VerfasserIn","display":"Wasmuth, Hermann"},{"role":"aut","display":"Trautwein, Christian","roleDisplay":"VerfasserIn","given":"Christian","family":"Trautwein"},{"roleDisplay":"VerfasserIn","display":"Streetz, Konrad L.","role":"aut","family":"Streetz","given":"Konrad L."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 04.05.2023"],"recId":"184459811X","language":["eng"],"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"16 December 2010"}],"id":{"eki":["184459811X"],"doi":["10.2353/ajpath.2010.090469"]},"name":{"displayForm":["Werner Plum, Darjus F. Tschaharganeh, Daniela C. Kroy, Eva Corsten, Stephanie Erschfeld, Uta Dierssen, Hermann Wasmuth, Christian Trautwein, and Konrad L. Streetz"]},"physDesc":[{"extent":"11 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1525-2191"],"eki":["271352906"],"zdb":["1480207-7"]},"origin":[{"publisherPlace":"New York [u.a.] ; Bethesda, Md.","dateIssuedDisp":"1925-","publisher":"Elsevier ; American Society for Investigative Pathology","dateIssuedKey":"1925"}],"part":{"pages":"2236-2246","issue":"5","year":"2010","extent":"11","volume":"176","text":"176(2010), 5 vom: Dez., Seite 2236-2246"},"pubHistory":["1.1925 -"],"recId":"271352906","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 19.02.2024"],"disp":"Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitisThe American journal of pathology","title":[{"title":"The American journal of pathology","subtitle":"cellular and molecular biology of disease ; official publication of the American Society for Investigative Pathology","title_sort":"American journal of pathology"}]}]} 
SRT |a PLUMWERNERLACKOFGLYC1620